MZZ:NYE-ProShares UltraShort MidCap400 (USD)

ETF | Trading--Inverse Equity |

Last Closing

USD 9.18

Change

+0.17 (+1.89)%

Market Cap

N/A

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-14 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Price(Change) Market Cap
SH ProShares Short S&P500

+0.28 (+0.67%)

USD 0.95B
SOXS Direxion Daily Semiconductor B..

+0.01 (+0.04%)

USD 0.66B
PSQ ProShares Short QQQ

+0.29 (+0.77%)

USD 0.61B
SPXU ProShares UltraPro Short S&P50..

+0.43 (+1.98%)

USD 0.51B
SDOW ProShares UltraPro Short Dow30

+0.69 (+1.47%)

USD 0.29B
YANG Direxion Daily FTSE China Bear..

+2.61 (+3.29%)

USD 0.17B
SPDN Direxion Daily S&P 500® Bear ..

+0.08 (+0.74%)

USD 0.14B
RWM ProShares Short Russell2000

+0.24 (+1.35%)

USD 0.14B
DOG ProShares Short Dow30

+0.14 (+0.54%)

USD 0.13B
DUST Direxion Daily Gold Miners Ind..

-0.67 (-1.02%)

USD 0.10B

ETFs Containing MZZ

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -26.97% 47% F 8% B-
Dividend Return 3.60% 72% C 57% F
Total Return -23.37% 47% F 8% B-
Trailing 12 Months  
Capital Gain -41.12% 49% F 4% F
Dividend Return 4.09% 72% C 53% F
Total Return -37.03% 49% F 4% F
Trailing 5 Years  
Capital Gain -84.69% 50% F 3% F
Dividend Return 2.08% 53% F 5% F
Total Return -82.61% 50% F 3% F
Average Annual (5 Year Horizon)  
Capital Gain 100.03% 51% F 97% N/A
Dividend Return 101.06% 51% F 97% N/A
Total Return 1.02% 51% F 24% F
Risk Return Profile  
Volatility (Standard Deviation) 697.51% 53% F 2% F
Risk Adjusted Return 14.49% 49% F 32% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.